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Abstract
The UL97 protein of human cytomegalovirus (HCMV, or HHV-5 (human herpesvirus 5)), is a kinase that phosphorylates the
cellular retinoblastoma (Rb) tumor suppressor and lamin A/C proteins that are also substrates of cellular cyclin-dependent
kinases (Cdks). A functional complementation assay has further shown that UL97 has authentic Cdk-like activity. The other
seven human herpesviruses each encode a kinase with sequence and positional homology to UL97. These UL97-
homologous proteins have been termed the conserved herpesvirus protein kinases (CHPKs) to distinguish them from other
human herpesvirus-encoded kinases. To determine if the Cdk-like activities of UL97 were shared by all of the CHPKs, we
individually expressed epitope-tagged alleles of each protein in human Saos-2 cells to test for Rb phosphorylation, human
U-2 OS cells to monitor nuclear lamina disruption and lamin A phosphorylation, or S. cerevisiae cdc28-13 mutant cells to
directly assay for Cdk function. We found that the ability to phosphorylate Rb and lamin A, and to disrupt the nuclear
lamina, was shared by all CHPKs from the beta- and gamma-herpesvirus families, but not by their alpha-herpesvirus
homologs. Similarly, all but one of the beta and gamma CHPKs displayed bona fide Cdk activity in S. cerevisiae, while the
alpha proteins did not. Thus, we have identified novel virally-encoded Cdk-like kinases, a nomenclature we abbreviate as v-
Cdks. Interestingly, we found that other, non-Cdk-related activities reported for UL97 (dispersion of promyelocytic leukemia
protein nuclear bodies (PML-NBs) and disruption of cytoplasmic or nuclear aggresomes) showed weak conservation among
the CHPKs that, in general, did not segregate to specific viral families. Therefore, the genomic and evolutionary conservation
of these kinases has not been fully maintained at the functional level. Our data indicate that these related kinases, some of
which are targets of approved or developmental antiviral drugs, are likely to serve both overlapping and non-overlapping
functions during viral infections.
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Introduction
Kinases catalyze the transfer of phosphate groups onto targeted
substrates. These phosphorylation events are fundamental to
proper cellular function and viability and help control enzyme
activity, signaling cascades, and protein trafficking, as well as a
multitude of other pathways and processes [1]. The enzymatic
activity of many kinases can be inhibited both potently and
specifically with small molecules, making them suitable drug
targets for clinical applications. In fact, kinases are now targets for
lung and breast cancer chemotherapies [2], and importantly, for
herpesviral infections as well [3,4].
The human herpesviruses (HHVs) are large, enveloped viruses
with double-stranded DNA genomes. Based on sequence homol-
ogy and cellular tropisms, they are divided into three families,
alpha, beta, and gamma. The alpha-herpesviruses are Herpes
Simplex Virus type 1 (HSV-1, HHV-1), type 2 (HSV-2, HHV-2),
and Varicella Zoster Virus (VZV, HHV-3). These viruses
complete productive (lytic) replication cycles in epithelial cells,
and establish life-long latency in sensory neurons. They cause
recurrent and sometimes painful skin lesions and, in rare cases,
meningitis [5,6]. The beta-herpesviruses are Human Cytomega-
lovirus (HCMV, HHV-5), and the roseolaviruses Human
Herpesviruses 6A and 6B (HHV-6), and Human Herpesvirus 7
(HHV-7). These viruses are classified as lymphotropic because
lymphocytes likely serve as a latent reservoir, but they replicate
productively in many cell types. Beta-herpesviruses cause severe
disease in patients with immature or compromised immune
function, and may exacerbate certain chronic ailments in
otherwise healthy patients [7,8]. The gamma-herpesviruses are
Epstein-Barr Virus (EBV, HHV-4) and Kaposi’s Sarcoma
Associated Herpesvirus (KSHV, HHV-8). These viruses are also
characterized by a lymphocyte tropism, but can also infect
epithelial and endothelial cells. They are causally associated with
human cancers [9,10].
As obligate intracellular parasites, viruses must manipulate
cellular processes to facilitate their own replication. Because
protein phosphorylation events are so crucial to cellular activity, it
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infections. While many (perhaps all) families of viruses manipulate
the activity of cellular kinases, only two families, the poxviruses
[11,12] and the herpesviruses [13,14,15] encode viral proteins
with confirmed kinase activity. However, rotavirus, a member of
the Reoviridae family of double stranded RNA viruses, encodes a
protein called NSP5 that may be a functional kinase [16].
At least eighteen human herpesvirus proteins are reported to
possess protein kinase activity. Sixteen of these are grouped into
three distinct families, (Us3, UL13 and thymidine kinase) based on
amino acid sequence homology (Table 1). The other two human
herpesvirus proteins reported to have kinase activity are HHV-2
ICP10 [17] and HHV-5 pp65 [18]. These proteins do not appear to
be members of any known viralkinasefamily. Among the conserved
kinase families, only alpha-herpesviruses encode the Us3 family of
kinases [14] that, among other functions, prevent apoptosis [19,20]
and disrupt the nuclear lamina [21,22,23]. Both the alpha- and
gamma-herpesviruses encode thymidine kinase family members
that, as their name implies, phosphorylate nucleosides, including
thymidine [24]. Importantly, viral thymidine kinases can also
phosphorylate unnatural nucleoside analogs (such as ganciclovir
and its derivatives) that act as chain terminators for viral DNA
replication, and constitute an important subset of anti-herpesviral
drugs [24]. The third family of herpesviral kinases was originally
termed the UL13 family [25,26]. However, because these represent
the only homologous kinases (at the level of genome position and
amino acid sequence) found in every human herpesvirus, they were
renamed the CHPKs for conserved herpesvirus-encoded protein
kinases [13,27]. The individual members of the human CHPKs are
named UL13 (HHV-1and -2), ORF47 (HHV-3),BGLF4 (HHV-4),
UL97 (HHV-5), U69 (HHV-6 and -7), and ORF36 (HHV-8)
(Table 2).
The CHPKs are not absolutely required for viral replication in
cell culture, but deletion mutants are severely attenuated for viral
growth [28,29,30,31,32]. They are expressed with early-late
kinetics and are incorporated into virions [33,34,35,36,37].
Demonstrated or postulated functions for the CHPKs during
viral replication include tegument disassembly [38,39], modula-
tion of gene expression [28,31,40], stimulation of viral DNA
replication [31,41,42,43], and facilitating capsid nuclear egress in
part through disruption of the nuclear lamina [31,44,45].
Recently, the CHPK encoded by the UL97 gene of HHV-5
(HCMV) was shown to directly phosphorylate the cellular
retinoblastoma (Rb) tumor suppressor protein both in vivo and in
vitro, on residues that are normally targeted by the cellular cyclin-
dependent kinase (Cdk) proteins that control cell cycle progression
[46,47]. UL97 was also found to phosphorylate lamin A/C
proteins in vitro on Cdk phosphorylation sites [45], and to rescue
the G1-to-S cell cycle defect of Saccharomyces cerevisiae cells lacking
Cdk function. Significantly, this yeast complementation assay
demonstrated that UL97 can functionally substitute for cellular
Cdks [46], indicating that the kinase has Cdk activity, and marking
UL97 as the first identified v-Cdk, an abbreviation for the term
virally-encoded Cdk-like kinase.
Here we show that the CHPKs encoded by the beta- and
gamma-herpesviruses are all capable of inducing Rb phosphory-
lation in vivo on residues that inactivate the cell cycle inhibitory and
tumor suppressor function of this protein. They can also induce
lamin A phosphorylation and disrupt the nuclear lamina.
Importantly, all the beta- and gamma-herpesvirus CHPKs, with
the exception of the HHV-8 (KSHV) ORF36 protein, displayed
authentic Cdk function in the yeast complementation assay. The
alphaherpesvirus CHPKs were unable to phosphorylate Rb or
lamin A, efficiently disrupt the nuclear lamina, or act as Cdks in S.
cerevisiae. When we assayed all eight kinases for additional non-Cdk
functions against cellular proteins that were previously reported for
UL97, we found that despite the evolutionary conservation of
these proteins, functional conservation was poor. Altogether, our
study identifies a subset of the CHPKs as viral Cdk-like kinases (v-
Cdks), but also indicates that the positional homology and amino
acid similarity of these protein kinases does not always translate
into common substrates or similar biological activities for these
proteins.
Results
Analysis of the steady state levels and sub-cellular
localization of ectopically-expressed, epitope-tagged
conserved herpesvirus protein kinases (CHPKs)
The CHPKs are grouped as a kinase family based on their
conserved genome location and limited sequence homology. While
Table 1. Kinases encoded by the human herpesviruses.
Virus (HHV) UL13 Family Us3 Family Thymidine Kinase
HSV-1 (1) UL13 Us3 UL23
HSV-2 (2) UL13 Us3 UL23
VZV (3) ORF47 ORF66 ORF36
EBV (4) BGLF4 BXLF1
HCMV (5) UL97
HHV-6 (6) U69
HHV-7 (7) U69
KSHV (8) ORF36 ORF21
Human herpesvirus-encoded (HHV) kinases are grouped into families based on
their sequence and positional homology. The commonly utilized gene or
protein name is listed.
doi:10.1371/journal.ppat.1001092.t001
Author Summary
The eight human herpesviruses are ubiquitous pathogens
associated with a wide spectrum of disease, and are
grouped into three families (alpha-, beta-, and gamma-)
based on sequence homology and tissue tropism. They
encode sixteen kinase proteins that are grouped into three
recognized families. Eight of these kinases, one from each
virus, are found at homologous positions in their
respective viral genomes and display limited but discern-
able amino acid similarity. These proteins have been
designated the CHPKs for conserved herpesvirus-encoded
protein kinases. We found that the beta and gamma
CHPKs, but not the alpha CHPKs, share at least a subset of
activities with the cellular cyclin-dependent kinases (Cdks)
that are key components of cell cycle regulation.
Furthermore, we discovered that the CHPKs, although
evolutionarily-conserved, showed a somewhat surprising
non-conservation of biological activities not associated
with cellular Cdks. Knowledge of functional as well as
sequence and positional conservation is essential for
understanding the evolutionary relationships among viral,
and between viral and cellular, kinases. Importantly,
because viral kinases are the targets of approved and
emerging antiviral treatments, cataloging both the com-
mon and unique activities of these proteins may help
predict or explain successes or failures during antiviral
drug development.
Viral Cyclin-Dependent-Like Kinases (v-Cdks)
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have been identified, a thorough functional comparison of this
group of kinases hasnotbeenreported.Upon the revelation that the
HHV-5 (HCMV) CHPK, the UL97 protein, was a viral Cdk
ortholog [46], we initiated experiments to determine if the other
CHPKs were also v-Cdks. We obtained an expression plasmid for
the HHV-2 CHPK which, upon transfection into mammalian cells,
produces an active kinase that is tagged with the hemagglutinin
(HA) epitope [48]. We then generated individual plasmids that
express HA epitope-tagged derivatives of the other seven CHPKs
(Table 2). Previous reports indicate that epitope-tagging does not
eliminate the kinase activity of the seven CHPKs for which such an
analysishasbeenconducted [48,49,50,51,52,53,54,55].Theactivity
of an epitope-tagged CHPK of HHV-7 has not been previously
examined. Verification of the correct CHPK sequence by direct
analysis (data not shown) and our finding that each tagged kinase
scored positive in at least one activity assay (Table 3) provide
confidence that our expression plasmids produced active kinases.
Although we cannot rule out changes in substrate specificity or
specific activity due to the epitope tag, we do note that tagged
CHPKs cancomplement the growthdefectsof HHV-4and HHV-5
mutant viruses lacking the untagged (wild type) CHPK gene
[52,56]. Importantly, the epitope tag allows us to monitor the
expression and localization of these eight different kinases with the
same antibody. Individual transfection of these eight plasmids into
human U-2 OS cells allowed for the production of the viral proteins
Table 2. CHPK alleles used in this study.
HHV number Common name Virus strain CHPK name Predicted MW Accession number KD mutation
1 HSV-1 KOS UL13 57 kDa HM584913 N/A
2 HSV-2 186 UL13 57 kDa NC_001798 N/A
3 VZV VZV32 ORF47 57 kDa AF314218.1 N/A
4 EBV B95-8 BGLF4 48 kDa DQ279927 K102I
5 HCMV AD169 UL97 78 kDa X17403 K355M
6 HHV-6 U1102 U69 64 kDa X83413.1 K218G
7 HHV-7 RK U69 63 kDa NC_001716 K202N
8 KSHV GK18 ORF36 50 kDa AF148805 K108Q
The indicated viral strains (delineated by the human herpesvirus number 1–8 as well as the commonly-used virus name) served as templates for PCR reactions
generating the CHPK alleles analyzed in this study. Accession numbers indicate the GenBank entries used for sequence confirmation. The amino acid substitutions in the
kinase-deficient (KD) mutant alleles are indicated.
doi:10.1371/journal.ppat.1001092.t002
Table 3. Summary of CHPK activities analyzed in this study.
CHPK Rb Lamina CDK PML-NB Aggresomes
Sh 807 780 821 Disruption P-Ser-22 Nuclear Cyto
1 2 2221765
P=0.14
5.960.09
P=0.08
2962
P=0.49
9.861.4
P=0.46
83±2
P=0.016
79610
P=0.19
2 2 22231±5
P=0.0098
42617
P=0.06
3366
P=0.10
7.261.3
P=0.11
41±3
P=0.0013
44±7
P=7.9E-5
3 2 2221261
P=0.30
6.761.6
P=0.44
3466
P=0.22
9.261.0
P=0.35
81±2
P=0.0098
8468
P=0.43
4 + + + + 70±7
P=0.0008
82±6.3
P=0.002
50±4
P=0.002
4.4±1.6
P=0.04
40625
P=0.065
32±15
P=0.0025
5 + + + + 72±4
P=3.4E-5
71±5.6
P=0.002
42±9
P=0.047
7.061.2
P=0.10
70±5
P=0.015
56±22
P=0.046
6 + + + + 68±7
P=0.0010
80±1.4
P=3.2E-7
49±5
P=0.006
8.562.0
P=0.26
86±2
P=0.03
8665
P=0.66
7 + + + ± 58±0.6
P=0.0016
75±3.3
P=5.2E-5
37±4
P=0.009
8.361.9
P=0.23
9164
P=0.39
8865
P=0.98
8 + + 2286±3
P=6.5E-6
71±3.2
P=5.9E-5
38610
P=0.10
6.662.2
P=0.09
9364
P=0.97
8666
P=0.64
EV 2 2229.963 3.2612 9 631 1 63.1 9360.7 8866
Results presented are displayed with standard deviation and P values (where applicable). A positive result for an individual activity is shown with bolded text. Rb
phosphorylation activities were determined qualitatively as readily apparent (+), marginal (6), or absent (2). For every other assay, assignment of functional activity
required statistical significance (P,0.05), and the experimental values obtained for the CHPK-positive cells are shown. Abbreviations are as follows: EV, no kinase
control; 1–8, CHPK of the indicated human herpesvirus; Sh, Rb phosphorylation detected by electrophoretic mobility shift; 807, 780, 821, Rb phosphorylation
demonstrated with antibodies that detect Rb only when phosphorylated on the indicated amino acid residue; Disruption, percentage of cells with disrupted nuclear
lamina; P-Ser-22, percentage of cells staining for lamin A phosphorylated on serine 22; CDK, percentage of budded cells in the yeast complementation assay; PML-NB,
average number of PML-NBs; Nuclear, percentage of cells containing nuclear aggresomes; Cyto, percentage of cells containing cytoplasmic aggresomes.
doi:10.1371/journal.ppat.1001092.t003
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migrated near the predicted molecular weight (Table 2) of the full-
length protein [34,35,57,58,59,60,61]. Adjusting the amount of
transfected plasmid DNA allowed us to identify experimental
conditions under which the steady state protein levels achieved for
six of these eight different proteins was consistent and comparable.
However, the CHPKs encoded by HHV-2 and HHV-5 often
accumulated to lower levels. Therefore, Western blot expression
controls are presented for each individual experiment.
The sub-cellular localization of the transfected CHPKs in U-2
OS cells was examined by fluorescence microscopy (Fig. 1A) and
quantitated (Fig. 1B) by visually determining the percentage of
cells with primarily nuclear localization of the kinase, primarily
cytoplasmic localization, or localization to both cellular compart-
ments. All of the kinases were found in both the nucleus and
cytoplasm in at least 25% of the transfected cells. The alpha-
herpesvirus CHPKs (HHV-1, -2, and -3) generally showed both
strong cytoplasmic and faint nuclear staining. Certain members of
the beta- and gamma-herpesvirus CHPKs showed predominantly
nuclear staining (HHV-4, -5, and -6), while others (HHV-7 and -8)
were more likely to be found in both cellular compartments. These
observed sub-cellular localizations are in agreement with previ-
ously published data [34,35,59,60,62,63].
Expression of the beta- and gamma- CHPKs leads to Rb
phosphorylation
The retinoblastoma (Rb) and lamin A/C proteins are
phosphorylated by the cyclin-dependent kinases (Cdks) that
control cell cycle progression. Rb is a tumor suppressor responsible
for regulating the G1/S cell cycle checkpoint [64]. Phosphoryla-
tion of Rb on specific Cdk-consensus sites results in the
dissociation of protein complexes between Rb, histone deacety-
lases (HDACs), and E2F transcription factors and allows for the
expression of E2F-responsive genes that drive progression through
G1 and entry into the S-phase of the cell cycle [64]. Certain E2F-
responsive genes also play critical roles in nucleotide biosynthesis
and DNA replication. Many DNA viruses partially rely on cellular
machinery for the replication of their genomes, and therefore
target Rb for inactivation during infection [65,66]. For example,
during HHV-5 (HCMV) infection, the UL97 CHPK is necessary
and sufficient for Rb inactivation through phosphorylation on Cdk
consensus sites [46]. Rb inactivation appears to be a critical
function of UL97 for efficient viral replication [67].
In vivo phosphorylation of Rb by an ectopically-expressed kinase
can be easily and reliably determined only in human Saos-2 cells.
These Rb-null osteosarcoma cells fail to phosphorylate ectopically-
expressed Rb unless a cyclin protein (cellular or viral) or UL97 is
included in the transfection [46,68,69]. Rb phosphorylation in
Saos-2 cells can be observed on Western blots by an electropho-
retic mobility shift of the protein to higher molecular weights, as
well as with phospho-specific antibodies that detect Rb proteins
only when phosphorylated on certain Cdk consensus sites. We
found that the CHPKs encoded by all of the beta- and gamma-
herpesviruses (HHV-4, -5, -6, -7, and -8) were able to
phosphorylate Rb when co-transfected into Saos-2 cells (Fig. 2A).
Phosphorylation was detected by both the shift in molecular
weight and with three independent phospho-specific antibodies
that detect Rb only when phosphorylated on specific Cdk
consensus sites that regulate association with the E2F proteins
[70,71]. Interestingly, the beta-herpesvirus CHPKs induced the
phosphorylation of Rb-inactivating residues to a substantially
higher degree than the gamma-herpesvirus proteins (Fig. 2A). The
alpha-herpesvirus proteins (HHV-1, -2, and -3) were unable to
phosphorylate Rb (Fig. 2A), as judged by both electrophoretic
Figure 1. Localization of the CHPKs in U-2 OS cells. (A) U-2 OS
cells plated on coverslips were transfected with expression plasmids
encoding each of the eight CHPKs (denoted by their human herpesvirus
number 1-8). Intracellular localization at 24 hours post transfection (hpt)
was analyzed by indirect immunofluorescence microscopy after
staining with anti-HA antibody (green) and counterstaining nuclei with
Hoechst (blue). (B) At least 300 kinase positive cells from the
experiment described above were scored for CHPK localization. The
percentage of cells displaying the indicated localization pattern
(primarily nuclear, primarily cytoplasmic, or both nuclear and cytoplas-
mic) for each CHPK (1–8) is shown.
doi:10.1371/journal.ppat.1001092.g001
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antibodies. The ability of the beta- and gamma-herpesvirus
CHPKs to phosphorylate Rb required that each protein was an
active kinase. Substitution of the catalytic lysine to create kinase-
inactive mutants inhibited the ability of the CHPKs to
phosphorylate Rb, shown by both molecular weight shift as well
as with the phospho-Rb-specific antibodies (Fig. 2B).
There was no correlation between steady state expression level
and the ability to phosphorylate Rb (Fig. 2A). CHPKs that
accumulated to high levels either did (e.g. HHV-4 and HHV-7) or
did not (e.g. HHV-3) phosphorylate Rb. Likewise, CHPKs that
accumulated only to low levels either did (e.g. HHV-5) or did not
(e.g. HHV-2) phosphorylate Rb. To further explore any potential
relationship between expression level and Rb phosphorylation, we
decreased the amount of HHV-4 and HHV-7 CHPK expression
plasmid transfected in an attempt to equalize, as much as possible,
the steady-state expression levels of these Rb-phosphorylating
kinases to the non-Rb-phosphorylating HHV-2 kinase. We found
that lower steady state levels of the HHV-4 and HHV-7 CHPK
still led to Rb phosphorylation (Fig. 2C), as seen by the shift in
apparent molecular weight. While substantial kinase overexpres-
sion may result in the phosphorylation of non-physiologic
substrates (false-positives), and low expression levels may prevent
detection of the phosphorylation of true substrates (false-negatives),
the data we present here are consistent with the conclusion that
the beta- and gamma-herpesvirus CHPKs, but not the alpha-
herpesvirus CHPKs, result in Rb phosphorylation when ectopi-
cally expressed.
The beta- and gamma- CHPKs induce lamin A
phosphorylation and lamina disruption
Like Rb, lamin A/C is also a Cdk substrate phosphorylated by
the CHPKs of HHV-4 and HHV-5 on Cdk consensus sites
[45,72]. Lamins are intermediate filament proteins that line the
inner nuclear membrane as part of the nuclear lamina [73].
During mitosis, the nuclear lamina is disassembled after
phosphorylation of lamin A/C by Cdk1 [73]. During viral
infections, the nuclear lamina likely represents a physical barrier
to herpesviral capsids that must leave the nucleus through
envelopment at the inner nuclear membrane. Thus, it has been
proposed that in order to gain access to the inner nuclear
membrane, herpesviruses must disrupt the nuclear lamina [74]. In
cells infected with HHV-1, HHV-4, and HHV-5, lamina
disruption is achieved through phosphorylation of lamin A/C on
Cdk consensus sites [23,45,72].
We found that beta- and gamma-herpesvirus CHPKs (HHV-4,
-5, -6, -7, and -8), but not those of the alpha-herpesviruses (HHV-
1, -2, and -3), were able to efficiently disrupt the nuclear lamina in
transfected U-2 OS cells (Fig. 3A). The nuclear lamina was
visualized by fluorescence microscopy in cells co-transfected with
expression plasmids for the CHPKs and human lamin A fused to
GFP. Western blots of the ectopically-expressed proteins are
Figure 2. The beta- and gamma-herpesvirus CHPKs phosphor-
ylate Rb. (A) Lysates from Saos-2 cells transfected with plasmids
encoding Rb and either an empty vector (EV) or one encoding the
indicated human herpesvirus (1–8) CHPKs were harvested 48 hpt and
analyzed by Western blot with the indicated antibodies. Rb, total Rb;
807, Rb phosphorylated on serine residues 807 and 811; 780, Rb
phosphorylated on serine 780; 821, Rb phosphorylated on threonine
821; HA, epitope tag; Tubulin, tubulin loading control. (B) Both wild
type and kinase-deficient (KD) alleles of the beta- and gamma-
herpesvirus CHPKs (4–8) were analyzed in the Saos-2 Rb phosphory-
lation assay as described above. (C) Lower levels of expression plasmids
for the HHV-4 and HHV-7 CHPKs were analyzed in the Saos-2 Rb
phosphorylation assay as described above. Please see the Materials and
Methods section for details.
doi:10.1371/journal.ppat.1001092.g002
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PLoS Pathogens | www.plospathogens.org 5 September 2010 | Volume 6 | Issue 9 | e1001092Figure 3. The beta- and gamma- herpesvirus CHPKs disrupt the nuclear lamina and phosphorylate lamin A. (A) U-2 OS cells plated on
coverslips were co-transfected with the indicated CHPK (1–8) or an empty vector (EV) and a plasmid expressing a GFP-lamin A fusion protein.
Coverslips were harvested at 24 hpt, stained for indirect immunofluorescence with an HA antibody and Hoechst (not pictured), and visualized by
fluorescence microscopy. Representative images showing GFP-lamin A (green) and the CHPK (red) are displayed. (B) At least 300 kinase and GFP-
lamin A positive cells from the experiment described above were scored for nuclear lamina disruption. The percentage of cells displaying a disrupted
GFP-lamin A signal for each CHPK (1–8) is shown. Error bars represent standard deviation. Double asterisks (**) indicate statistically significant
Viral Cyclin-Dependent-Like Kinases (v-Cdks)
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transfected cells show a dim GFP signal throughout the body of
the nucleus that is brighter where lamin A/C concentrates at the
nuclear periphery (see the panel with empty vector co-transfected
cells, Fig. 3A, bottom right). Co-expression (visualized by indirect
immunofluorescence with an HA antibody) of the beta- and
gamma-herpesvirus CHPKs, and to a lesser extent the HHV-2
CHPK, caused a redistribution of GFP from the ring-like signal
around the nuclear perimeter into large punctate spots found
throughout the nucleus (Fig. 3A) in the majority of cells imaged.
For these CHPKs, the percentage of kinase-positive cells showing
disrupted nuclear lamina was statistically different than cells
transfected with GFP-lamin A and an empty vector control
(Fig. 3B). The HHV-1 and HHV-3 alphaherpesvirus CHPKs did
not visibly disrupt the nuclear lamina at a frequency distinguish-
able from empty vector transfected cells.
We also examined the ability of ectopically-expressed CHPKs to
direct the phosphorylation of the endogenous lamin A protein at
serine-22. Phosphorylation of this and other lamin A residues by
cellular Cdk1 initiates the process of lamina breakdown during
mitosis [75]. Matching our results from the GFP-lamin experi-
ments (Fig. 3A and 3B), the alpha-herpesvirus CHPKs were
unable to induce serine-22 phosphorylation (Fig. 3C and 3F),
whereas the beta- (Figure 3D and 3F) and gamma-herpesvirus
CHPKs (Fig. 3E and 3F) did induce serine-22 phosphorylation.
Kinase-inactive mutants of the beta- and gamma-herpesvirus
CHPKs were unable to induce serine-22 phosphorylation.
Western blots of the ectopically-expressed CHPKs are shown in
Figure S2, and quantitation of the data is shown in Figure 3F.
The HHV-2 CHPK showed low level lamina disruption that
was statistically different from an empty vector control (Fig. 3B). A
similar level of serine-22 phosphorylation was observed, although
the difference from the empty vector control did not reach
statistical significance. Thus, although the HHV-2 CHPK may
retain some ability to phosphorylate lamin A, (perhaps more
efficiently in the tail region) and to disrupt the nuclear lamina [76],
we conclude that these activities are, in general, absent from the
alpha-herpesvirus CHPKs, but present in the beta- and gamma-
herpesvirus CHPKs. Although experiments of this type are often
cited as evidence that CHPK-mediated lamin A/C phosphoryla-
tion directly leads to lamina disruption, we note that they cannot
rule out other mechanisms for lamina disruption upon CHPK
expression or herpesvirus infection (such as lamin B or lamin
receptor phosphorylation) in addition to or instead of lamin A/C
phosphorylation.
Beta- and gamma-herpesvirus CHPKs function as cyclin
dependent kinases (Cdks)
The first human Cdk was cloned by genetic complementation of
Cdk mutant yeast cells [77]. Unlike higher eukaryotes, S. cerevisiae
encodes only a single Cdk, the CDC28 gene. Yeast cells harboring
a temperature-sensitive mutant allele of this gene (cdc28-13) exhibit
growth arrest in G1 phase upon a shift to the restrictive
temperature [78]. Expression of a functional human Cdk in
cdc28-13 cells rescues this arrest phenotype [79]. Expression of the
HHV-5 (HCMV) CHPK, the UL97 protein, in cdc28-13 yeast cells
also rescued the cell cycle arrest phenotype at the restrictive
temperature, indicating that it has authentic Cdk activity, and
identifying UL97 as the first known viral functional ortholog of a
Cdk [46].
We used the same assay to determine if the other CHPKs were
also genuine Cdks. Asynchronously growing cdc28-13 yeast cells
harboring plasmids expressing the CHPKs under the control of
the GAL1 promoter were shifted to the restrictive temperature to
inactivate the sole yeast Cdk, and grown in the presence of
galactose to induce the expression of the CHPK. Western blots of
the ectopically-expressed CHPKs are shown in Figure S3. Five
hours later, cell cycle progression through G1 was verified by
determining the number of budded cells. In the absence of an
ectopic Cdk, cdc28-13 cells grown at the restrictive temperature
arrested in the G1 phase of the cell cycle as unbudded cells
[46,78], (Fig. 4). However, as was previously observed [46],
ectopic expression of human Cdk1, and to a lesser extent the
HHV-5 CHPK permitted cell cycle progression through G1 and
into S phase of cdc28-13 cells grown at the restrictive temperature,
as evidenced by an increase in the number of budded cells (Fig. 4).
This result is indicative of authentic Cdk function. Expression of
the other beta-herpesvirus CHPKs (HHV-6 and -7) and the
CHPK from the HHV-4 gamma-herpesvirus also rescued the cell
cycle defect of cdc28-13 yeast grown at the restrictive temperature
(Fig. 4), indicating that they also have genuine Cdk activity. The
HHV-8 gamma-herpesvirus CHPK, the ORF36 protein of
KSHV, failed to produce a statistically significant increase in
cdc28-13 budded cells at the restrictive temperature (Fig. 4),
although it did display substantial Cdk activity in one of the three
experiments performed. Interestingly, KSHV is the only human
herpesvirus to encode a viral cyclin [80]. The KSHV cyclin pairs
with and activates human Cdks, perhaps obviating the need for
Cdk function of the viral CHPK. As expected from their inability
to phosphorylate Rb or lamin A/C, the alpha-herpesvirus CHPKs
did not display Cdk activity in this assay. Note that we cannot rule
out the possibility that the alpha-herpesvirus proteins might not be
active when expressed in yeast cells. In total, the Rb, lamin, and
yeast experiments functionally define the beta- and gamma-
herpesvirus CHPKs as viral cyclin-dependent-like kinases, or v-
Cdks.
The HHV-4 protein (EBV-BGLF4) is the CHPK that most
efficiently disrupts PML-NBs
While the CHPKs are grouped as a family based upon their
positional homology and limited amino acid similarity, our data
indicate that only the beta- and gamma-herpesvirus CHPKs are v-
Cdks. These observations indicate that the evolutionary relation-
ship of these eight kinases does not translate to a complete
conservation of Cdk-like function. To determine if other functions
of these kinases may have been more widely conserved throughout
evolution, we screened each kinase for their ability to disrupt
PML-NBs, nuclear aggresomes, and cytoplasmic aggresomes, all
differences from empty vector (EV) transfected cells (P#0.01). (C) U-2 OS cells plated on coverslips were transfected with the indicated alpha-
herpesvirus CHPK (1–3) or an empty vector (EV) and then cultured in low serum media. Coverslips were harvested at 36 hpt and stained for indirect
immunofluorescence with an HA antibody to detect the CHPK (Kinase), an antibody that detects lamin A only when phosphorylated on Ser-22 (P-Ser
22), and Hoechst (Nuclei). (D) Beta-herpesvirus CHPKs (5–7) or their kinase deficient counterparts (KD) were analyzed as described above. (E) Gamma-
herpesvirus CHPKs (4,8) or their kinase deficient counterparts (KD) were analyzed as described above. (F) Cells from the experiments described above
(C–E) were scored for lamin A phosphorylation on serine-22. The percentage of cells displaying lamin phosphorylation for wild type (1–8) and KD (4–
8) CHPKs is shown. Error bars represent standard deviation. Double asterisks (**) indicate statistically significant differences from empty vector (EV)
transfected cells (P#0.01).
doi:10.1371/journal.ppat.1001092.g003
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UL97, the HHV-5 (HCMV) CHPK [47].
Promyelocytic Leukemia Nuclear Bodies (PML-NBs) are sub-
nuclear structures that appear as multiple punctate spots within
the nucleus and are involved in a wide array of cellular activities
[81]. During infections with HHV-1, new PML-NBs are generated
at the sites where infecting viral genomes enter the nucleus [82].
HHV-5 genomes also co-localize with PML-NBs shortly after
infection [83]. Proteins that localize to PML-NBs institute an
intrinsic cellular defense against these herpesviruses by silencing
viral immediate early (IE) gene expression [84,85]. Viral proteins
delivered to cells upon virion entry and/or expressed as IE genes
inactivate this defense and disrupt PML-NBs [86,87,88].
We used U-2 OS cells and indirect immunofluorescent
detection of the PML protein (Fig. 5A) to monitor the effects of
ectopically-expressed CHPKs on PML-NBs. Western blots of the
ectopically-expressed CHPKs are shown in Figure S4. As
expected, we found that the number of PML-NBs in U-2 OS
cells resembles a Gaussian distribution between 4 and 24 (Fig. 5B),
with an average of 11 per cell (Table 3). Our average agrees well
with previously reported data [63]. We used HCMV IE1 as a
positive control for PML-NB disruption [86], and counted the
number of PML-NBs in 100 CHPK-positive nuclei in three
separate experiments. With the exception of HHV-1 and HHV-3,
expression of all of the other CHPKs resulted in a perceptible shift
in the distribution of PML-NBs per cell towards lower numbers
(Fig. 5B). Most of the shifts were small, although the HHV-5 and
HHV-8 CHPKs showed more substantial effects. However, only
the HHV-4 CHPK caused a drop in the average number of PML-
NBs per cell that was statistically different than control cells
(Table 3).
Disruption of nuclear and cytoplasmic protein
aggregates by the CHPKs
High synthesis rates, cellular stresses, and other stimuli can lead
to protein aggregation and the formation of aggresomes. Ectopic
expression of the HHV-5 (HCMV) CHPK (UL97) in uninfected
cells has been shown to disrupt aggregates of viral proteins as well
as nuclear and cytoplasmic aggresomes formed by GFP-GCP170*,
an artificial stimulator of aggresome formation [47,53]. Converse-
ly, GFP-GCP170* aggregates have been detected in HHV-1
infected cells [89], implying that the HHV-1 CHPK may not
disrupt aggresomes.
To determine if aggresome disruption was a general feature of
the CHPKs, we tested the ability of the kinases to disrupt nuclear
or cytoplasmic aggresomes formed by the ataxin-1 protein. Ataxin-
1 (Atx1) has a poly-glutamine tract that, when expanded beyond
40 amino acids, produces a protein with a non-native conforma-
tion that forms aggregates, is cytotoxic, and causes spinocerebellar
ataxia type 1 [90]. We co-transfected cells with the CHPKs and
FLAG-tagged derivatives of either Atx1(Q82) or Atx1(Q82)-
K772T that form aggregates in the nucleus and cytoplasm,
respectively [90]. Western blots of the ectopically-expressed
proteins are shown in Figure S5. The presence of at least one
aggregate or the total absence of aggregates in ataxin-expressing
cells (Fig. 6A and 6C) was determined for at least 200 CHPK-
positive cells in at least three independent experiments. We found
that the HHV-2 and HHV-5 CHPKs resulted in a statistically
significant decrease in the number of cells in which ataxin-1 could
form both nuclear (Fig. 6A and 6B) and cytoplasmic (Fig. 6C and
6D) aggregates even though these were the CHPKs expressed to
the lowest level (Figure S5). CHPKs encoded by HHV-1, -3, -4,
and -6 caused a statistically significant decrease in cells with either
nuclear or cytoplasmic aggresomes, but not both (Fig. 6). While
the HHV-4 CHPK caused a substantial decrease in the percentage
of cells containing nuclear aggresomes, the wide variability in the
numbers accumulated over three independent experiments
resulted in data that did not achieve statistical significance
(Fig. 6B). Our data confirm previous results demonstrating that
the HHV-5 CHPK can either prevent or disrupt protein
aggregation [47], but also indicate that this ability is not well
conserved among the eight CHPKs.
In summary, we found that the most conserved activity of the
CHPKs is their Cdk-like function. However, this is only found in
the beta-and gamma-herpesvirus members, and is absent in the
alpha-herpesvirus proteins. The non-Cdk-like activities reported
for the HHV-5 CHPK, the HCMV UL97 protein, are poorly
conserved among the other family members. Thus the functional
conservation between these eight kinases as a whole, much like
their amino acid sequence similarity, is limited.
Discussion
Cellular substrates of selected CHPKs that are normally
phosphorylated by the Cdks in uninfected cells have been
identified. These include Rb [46,47], lamin A/C [45,72],
translation elongation factor 1 delta [49], the carboxy-terminal
domain of RNA Polymerase II [91], the helicase complex
component MCM4 [92], the condensin protein involved in
chromatin packaging [93], and the Cdk inhibitor p27 [51].
However, only the CHPK encoded by HHV-5, the HCMV UL97
Figure 4. A subset of CHPKs display CDK activity. S. cerevisiae
cdc28-13 strains growing in glucose at the permissive temperature and
harboring galactose-inducible expression plasmids for the indicated
proteins (Empty Vector, EV; human cyclin-dependent kinase 1, CDK1;
CHPKs (1–8)) were transferred to galactose-containing media and
shifted to the restrictive temperature for five hours, at which time
budded cells (indicative of continued cell cycle progression) were
counted by light microscopy. The percentage of budded cells is shown
with standard deviation. Asterisks denote statistically significant
differences from the empty vector control (* indicates P#0.05, **
indicates P#0.01).
doi:10.1371/journal.ppat.1001092.g004
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this study, we examined the remainder of the CHPKs for Cdk-like
activity, as well as non-Cdk-like activities previously reported for
UL97. We employed the yeast complementation assay because it is
the most basic and stringent test for Cdk activity, and the Saos-2
assay because it is the most widely-accepted assay for demonstrat-
ing Rb phosphorylation in vivo by a co-transfected protein. For all
other experiments, we used U-2 OS cells because they transfect
well, do not express a transforming viral oncogene, and represent a
generic human cell (the differing cellular tropisms of the eight
human herpesviruses prevented us from using a more physiolog-
ically relevant cell type). Effects on cellular targets or processes (as
opposed to viral ones) were analyzed so that activity against
identical (as opposed to just homologous) substrates could be
monitored.
Our results indicate that Cdk-like activity is absent in the
alpha-herpesvirus CHPKs, as they were unable to induce Rb or
lamin A phosphorylation, lamina disassembly, or yeast cdc28-13
cell cycle progression. These results agree well with the
observations that Rb is not phosphorylated in cells infected with
HHV-1, HHV-2, or HHV-3 [66], but is phosphorylated in cells
infected with HHV-4 and HHV-5, [94,95], representative
members of the beta- and gamma-herpesvirus families. Our
lamin results are also mostly consistent with previously published
data. Although it is clear that lamin A/C becomes phosphory-
lated in cells infected with representative members of the alpha-
[23], beta- [45], and gamma- [72] herpesviruses, different kinase
families appear to be responsible for these phosphorylation
events. A recent analysis [72] found that, in addition to the
HHV-4, HHV-5 [96], and HHV-8 CHPKs, the HHV-1 CHPK
was able to disrupt the nuclear lamina in HeLa cells [72],
however, we detected no activity of the HHV-1 protein in two
independent lamin assays (Fig. 3). It is unclear if expression of the
papillomavirus E7 oncoprotein in HeLa cells, a known stimulator
Figure 5. The CHPKs show minor effects on the numbers of PML-NBs per cell. (A) U-2 OS cells plated on coverslips were transfected with
the indicated CHPK (1–8) or HCMV IE1 and 24 hours later were harvested and stained for indirect immunofluorescence with antibodies for PML, the
HA epitope, and Hoechst (not pictured). Representative images showing PML (green) and the CHPK or IE1 (red) are displayed. Arrows denote CHPK/
IE1 expressing cells. Images are grouped into the alpha-herpesvirus proteins (top), beta-herpesvirus proteins (middle), and gamma-herpesvirus
proteins plus the IE1 control (bottom) (B) Using the same coverslips as in A, the number of PML-NB domains was counted in at least 100 kinase
positive nuclei for three independent experiments. The frequency with which any specific number of PML-NBs was observed in an individual cell was
plotted with Microsoft Excel as a best-fit curve. Control (dashed line) and IE1 expressing cells (black line) are shown in each graph for comparison. The
average number of PML-NBs per cell was also determined from this data (see Table 3) and statistically significant differences from control cells are
denoted with an asterisk (* indicates P#0.05). Herpesvirus families are grouped as above.
doi:10.1371/journal.ppat.1001092.g005
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here, could explain this difference between the two studies. Thus,
although previous studies [72,76] and our own data with the
HHV-2 CHPK (Fig. 3) indicate that the alpha-herpesvirus
CHPKs may retain some ability to phosphorylate lamin A/C
and to disrupt the nuclear lamina, we suspect, as others have
shown, that the members of the alpha-herpesvirus-specific Us3
family of kinases are largely responsible for this activity in virus-
infected cells [21,22,23,98]. Thus, we conclude that the alpha-
herpesvirus CHPKs do not mimic cellular Cdk activity.
Interestingly, cellular Cdks are active during, and required for
efficient alpha-herpesvirus replication [66]. The critical substrates
for cellular Cdks in alpha-herpesvirus infected cells remain to be
determined.
Figure 6. Assorted CHPKs prevent nuclear and/or cytoplasmic aggresome formation. (A) U-2 OS cells grown on coverslips were
transfected with expression plasmids for Flag epitope tagged Ataxin-Q82 (a spontaneously aggregating protein) as well as the indicated CHPKs (1–8)
or an empty vector (EV). Coverslips were harvested 24 hpt and stained for indirect immunofluorescence with antibodies against the Flag epitope, the
HA epitope, and Hoechst. Representative images showing Ataxin-Q82 (green), the CHPK (red) and counterstained nuclei (blue) are displayed. (B)
Using the same coverslips as in A, the number of cells that contained nuclear aggresomes was determined by counting between 200 and 300 Ataxin-
Q82 positive cells in three independent experiments. The percentage of kinase and Ataxin-Q82 positive cells that formed nuclear aggresomes is
shown with standard deviation. Asterisks denote statistically significant differences from the empty vector control (* indicates P#0.05, ** indicates
P#0.01). (C) Cytoplasmic aggregates formed by the Ataxin-Q82-K772T were imaged as in (A) above. (D) Cytoplasmic aggresomes were quantitated as
in B above except that four independent experiments were analyzed.
doi:10.1371/journal.ppat.1001092.g006
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found to possess Cdk-like activity. All of these proteins phosphor-
ylated Rb and disrupted the nuclear lamina, and all but one
rescued cell cycle progression in the yeast complementation assay.
It is presently undetermined what (if any) advantage encoding and
expressing their own Cdk-like protein affords these viruses that
utilization of cellular Cdk activity would not. Nevertheless, this
analysis, along with our previous study [46] identifies the HHV-4
(EBV-BGLF4), HHV-5 (HCMV-UL97), HHV-6 (U69), HHV-7
(U69), and HHV-8 (KSHV-ORF36) CHPKs as virally-encoded
cyclin-dependent-like kinases, or v-Cdks.
Unlike cellular Cdks, the HHV-5 CHPK (HCMV UL97), the
first identified v-Cdk, lacks many of the regulatory features that
restrict kinase activity during certain stages of the cell cycle or
under physiological stresses [46]. For example, UL97 lacks
conserved sequences for cyclin binding and appears to have
cyclin-independent kinase activity. UL97 has an amino acid
substitution at the Cdk site (Thr 160 of Cdk2) of phosphorylation
by Cdk activating kinase (CAK), and is active under conditions of
CAK inhibition. UL97 lacks amino acid residues important for
binding both the Cip/Kip and INK classes of cyclin-dependent
kinase inhibitors, and is immune to inhibition by p21
WAF1/CIP1 in
vivo and in vitro. Finally, UL97 has a phenylalanine substitution for
a tyrosine residue (Tyr 15 of Cdk2) found in Cdks which, when
phosphorylated in G2 phase or in response to DNA damage,
attenuates kinase activity.
A sequence alignment of the other v-Cdks showed that, like
UL97, none of these kinases contain the cyclin-binding, cyclin-
dependent kinase inhibitor-binding, or CAK phosphorylation
motifs found in the cellular Cdks (Fig. 7). Thus, the newly-
identified v-Cdks lack many of the amino acids and protein
domains responsible for regulating the activity of their cellular
functional orthologs. Interestingly, all of the v-Cdks except UL97
and KSHV ORF36 (the HHV-8 CHPK) do contain the tyrosine
residue that, in cellular Cdks, allows for the attenuation of kinase
activity upon phosphorylation. Whether or not this amino acid
substitution affects kinase activity during viral infection remains to
be examined.
In the past, designation as a Cdk required not only sequence
and functional homology to known Cdks, but also experimental
evidence that the activity of the kinase was dependent upon
association with a cyclin regulatory subunit [99]. However, a
recent nomenclature adjustment has grouped all human and
murine kinases with sequence and functional similarity to Cdks
into the Cdk family, even if cyclin binding has not been observed
or is not expected [100]. Thus, while the beta- and gamma-
herpesvirus CHPKs do not appear to require cyclin binding for
activity, describing these proteins as v-Cdks is in accordance with
the accepted classification system because they are related to true
Cdks by amino acid sequence (Fig. 7), and because they mimic
Cdk activity (Fig. 2, Fig. 3, Fig. 4, Table 3) even though they are
likely not regulated in an identical fashion to cellular Cdks.
The lack of conservation of Cdk activity in the alpha-
herpesvirus CHPKs was surprising based on the strong evolution-
ary relationship of this family of proteins, and prompted us to ask if
non-Cdk-like functions were more conserved throughout the
CHPK family. Interestingly, we found that non-Cdk-like functions
were even less well conserved than Cdk activity (Table 3). Only the
HHV-4 CHPK mediated a decrease in PML-NB numbers per cell
that reached statistical significance, although other kinases, most
notably the HHV-5 and HHV-8 CHPKs, clearly appeared to
affect these structures. This finding varies considerably from
previous reports, perhaps because of different experimental
approaches. Our study used a version of the HHV-4 CHPK
tagged at the amino-terminus with the 9 amino acid HA epitope
tag, while a previous examination of this protein that failed to
demonstrate PML-NB disruption [63] used a 69 amino acid SPA
tag at the carboxy-terminus. The differences in tag size and
location may affect kinase activity, which was not directly
examined in the other study [63], but has been demonstrated
here (Fig. 2). A study that concluded the HHV-5 CHPK disrupted
PML-NBs [47] was conducted in Cos7 cells that express the
simian virus 40 (SV40) tumor (T) antigen, and monitored Sp100
localization as a measure of PML-NBs. Our study visualized PML,
the sole protein required for PML-NB formation, in U-2 OS cells
that do not express a transforming viral oncogene. It is currently
unknown which if any of these differences may explain why the
subtle effects on PML-NB distribution that we observed upon
expression of the HHV-5 CHPK failed to reach statistical
significance.
Proteins that efficiently disrupt PML-NBs (HCMV IE1 and
EBV Zta) are expressed within infected cells in vitro prior to the
time when the CHPKs are expressed [101,102], so the ability of
the HHV-4 and HHV-5 CHPKs to decrease the numbers of
PML-NBs when ectopically expressed may have limited relevance
during viral infection. Furthermore, because the proteins that
localize to PML-NBs and not the PML-NB structures themselves
appear to be the mediators of an intrinsic antiviral defense [84,85],
the significance of the ability of these viral proteins to reduce the
number of, but not eliminate PML-NBs from cells is unclear,
especially since it is unknown whether or not any PML-NB
resident proteins are direct substrates of these kinases. Therefore,
perhaps unsurprisingly, the ability to disrupt PML-NBs appears to
be an activity not well conserved throughout the CHPK family.
Disruption of protein aggregates termed aggresomes is another
non-Cdk function attributed to the HHV-5 CHPK. Aggresomes
have been hypothesized to represent a cellular anti-viral defense
that identifies, initially sequesters, and ultimately disposes of viral
proteins to inhibit viral replication [103]. Thus, aggresome
disruption could potentially enhance viral infections. However,
aggresome formation is also thought to sequester misfolded
proteins and perhaps facilitate their degradation by the protea-
some or through autophagy [103]. In addition, viruses may
commandeer aggresome formation pathways to help form
replication or assembly compartments [103]. In these respects,
aggresome formation would appear to enhance virus replication.
Different human herpesviruses appear to present examples
where aggresome formation has opposing effects on viral
replication. Structures morphologically resembling aggresomes
form in both the nuclei and cytoplasm of cells infected with HHV-
1 and -2 (the herpes simplex viruses) or HHV-5 (HCMV). At early
times after HHV-1 infection, aggregates containing viral proteins,
cellular chaperones, and proteasomes form in the nucleus [104].
These virus-induced chaperone enriched (VICE) domains are
proposed to be sites where misfolded proteins are sequestered
away from virus replication compartments, perhaps to facilitate
either their proper folding or degradation, as well as to prevent the
misfolded proteins from triggering cellular processes deleterious to
virus infection such as apoptosis or the unfolded protein response
[105]. At late times after HHV-2 infection, similar structures form
in the cytoplasm [106]. Disruption of these cytoplasmic aggre-
some-like structures correlates with decreased HHV-2 yields
[106], indicating that the integrity of these structures may
positively influence viral infection. In contrast, the disruption of
aggresomes may facilitate HHV-5 replication. Cells infected with
an HHV-5 mutant lacking its CHPK contain nuclear and
cytoplasmic aggresome-like structures that are absent during wild
type-infection [53], and produce fewer infectious progeny virions
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PLoS Pathogens | www.plospathogens.org 11 September 2010 | Volume 6 | Issue 9 | e1001092Figure 7. v-Cdks lack conserved cellular Cdk residues that allow for the regulation of kinase activity. The amino acid sequences of the
kinase domains of the indicated viral (top) and human (bottom) Cdks were aligned. Conserved kinase subdomains are indicated with Roman
numerals [118]. The residue corresponding to tyrosine 15 of Cdk2 is shown in green. The residue corresponding to threonine 160 of Cdk2 is shown in
lavender. Amino acids that mediate cellular Cdk binding to p27 [119], a member of the Cip/Kip class of cyclin-dependent kinase inhibitors, are shown
in red. Amino acids that mediate cellular Cdk binding to p16 [120], a member of the INK family of cyclin-dependent kinase inhibitors, are shown in
blue. The cyclin-binding PSTAIRE sequence in the cellular Cdks is boxed [121], and other residues shown to be important for CDK2 binding to Cyclin A
are shown in orange [121]. The catalytic triad residues are marked with asterisks (*) [118].
doi:10.1371/journal.ppat.1001092.g007
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hypothesis that aggresomes may represent a cellular anti-viral
defense, and that one role for the HHV-5 CHPK during viral
infection is to prevent their formation [47].
Only one CHPK from each family (alpha, HHV-2; beta, HHV-
5; and gamma, HHV-4) disrupted cytoplasmic aggresomes.
However, disruption of nuclear aggresomes was the one activity
that could conceivably be considered as conserved among these
kinases, even though the magnitude of this disruption was minimal
in some cases. All of the three alpha-herpesvirus CHPKs scored
positive for this assay, as did two (HHV-5 and HHV-6) of the three
beta-herpesvirus CHPKs. While our statistical analysis argues that
both gamma-herpesvirus proteins are devoid of this activity, the
HHV-4 CHPK clearly appeared to have an effect on these
structures.
Because, for the most part, the non-Cdk-like activities we
examined do not segregate to specific viral families (as Cdk activity
does), we suggest that cellular proteins that are substrates for
individual CHPKs, but not the Cdks, may represent a more
divergent set of proteins than might be expected based upon the
evolutionary relationship of these kinases. Furthermore, our data
suggest that the v-Cdks may have an expanded repertoire of
substrates as compared to the alpha-herpesvirus CHPKs. This
may not be surprising because the alpha-herpesvirus-specific Us3-
family kinases appear to assume at least one v-Cdk role, lamina
disruption [21,22,23], during viral infection. Whether or not a
comprehensive analysis of kinase activity against homologous viral
proteins would reveal more conservation of function throughout
the CHPK family awaits further examination.
An alternative strategy to assay for functional conservation
among the CHPKs would be to determine if other members of the
kinase family could complement the growth defect observed in
viruses lacking their endogenous CHPK. The few experiments
that have been performed support the contention that the v-Cdks
have a partially overlapping but also extended substrate range
when compared to the alpha-herpesvirus CHPKs. Expression of
the HHV-5 CHPK from an HHV-1 genome in which its CHPK
was deleted resulted in a complete restoration of progeny virion
formation at both high and low multiplicities of infection [107],
indicating that this v-Cdk can perform all the necessary functions
for viral replication normally carried out by the HHV-1 CHPK.
However, when expressed from a recombinant adenovirus, the
HHV-1 CHPK was unable to rescue the growth of an HHV-5
CHPK null-mutant virus [108]. Interestingly, that same series of
experiments demonstrated that the HHV-4 CHPK could partially
complement the growth defect of the HHV-5 CHPK mutant
virus, indicating that there is substantially more functional overlap
within the v-Cdks than between the v-Cdks and the alpha-
herpesvirus CHPKs. A comprehensive genetic analysis of inter-
virus CHPK complementation should increase our understanding
of the evolutionary path that these viral kinases have traveled, as
well as helping to define their critical roles during viral infection.
In all eight human herpesviruses, the CHPK gene is found in a
conserved genomic block and is flanked on either side by
homologous genes [109,110], likely indicating that the current
CHPK genes are descended from a single primordial precursor.
Over time, the functions of this putative CHPK precursor appear
to have diversified differently among these eight viruses. Thus
while they represent a single historical kinase family, it may be
more practical to consider the CHPK family as representing two
individual clades, the UL13s and the v-Cdks. An evolutionary tree
diagram of the sixteen shared human herpesvirus kinases (Fig. 8)
clearly shows their segregation into different families and clades.
Whether the putative primordial CHPK was a Cdk whose Cdk-
like activity was lost in the alpha-herpesvirus lineage, or whether it
was a kinase that evolved to acquire Cdk-like function in the beta-
and gamma-herpesviruses is an interesting topic for speculation
and debate.
Materials and Methods
Cells and transfections
U-2 OS human osteosarcoma cells were grown in a 5% CO2
atmosphere at 37uC in Dulbecco’s modified Eagle’s medium
(Invitrogen) supplemented with 10% (vol/vol) fetal bovine serum
(Gemini), 100 U/ml penicillin, 100 ug/ml streptomycin, and
0.292 mg/ml glutamine (Gibco). Cells (2610
6) were seeded on
10 cm plates five hours prior to transfection by the calcium
phosphate co-precipitation method. After an overnight incubation,
the cells were washed twice with medium and then re-fed with
serum-containing media (time zero). Different amounts of CHPK
expression plasmid DNA were transfected (HHV-2, -5, -7, 15 mg;
HHV-1 and -8, 10 mg; HHV-3, 5 mg; HHV-4, 2mg; HHV-6, 1mg)
in order to approximately equalize steady state protein levels.
Total DNA levels in transfections were balanced with pGEM7
(Promega). Saos-2 cells were grown as above, seeded at a density of
8610
5 cells per 60 mm dish, and transfected 5 hours later with
TransIT-2020 (Mirus) according to the manufacturer’s instruc-
tions. Along with 1mg of Rb expression plasmid, different amounts
of CHPK expression plasmid DNA were transfected (HHV-2, -5,
-5KD, 1.5 mg; HHV-1, -7, -7KD, -8KD, 1 mg; HHV-8, 0.15 mg;
HHV-3, -4KD, -6, -6KD, 0.1 mg; HHV-4, 0.05 mg). Transfection
conditions for the experiment in Figure 2C were the same except
0.01 mg was transfected for HHV-4, and 0.2 mg for HHV-7.
CHPK expression plasmids
Kinase alleles (except HHV-2) were amplified by PCR,
sequence verified (see Table 2), and subsequently cloned into the
pCGN vector that adds an N-terminal hemagglutinin (HA)
Figure 8. Tree diagram of the human herpesvirus kinases.
Amino acid sequence comparison was used to generate a tree diagram
showing the interrelatedness of sixteen human herpesvirus kinases. The
segregation of the kinases into the Us3, TK, and CHPK families, and the
separation of the CHPK family into the UL13 and v-Cdk clades is shown.
Line distances represent relative evolutionary separation. The com-
monly-used names for the human herpesviruses are shown (see
Table 2).
doi:10.1371/journal.ppat.1001092.g008
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immediate early promoter. HA-tagged alleles for all of the CHPKs
except HHV-5 were also cloned into the yeast expression vector
pMSS78 under the control of the yeast GAL1 promoter [111]. The
plasmid that expresses V5 epitope-tagged HHV-5 CHPK in yeast
has been previously described [46]. Kinase-deficient (KD) mutants
(Table 2) were created by standard mutagenesis approaches and
confirmed by complete sequencing of the mutant allele. PCR
templates were as follows: HHV-1, viral genomic DNA strain
KOS, a gift from Curtis Brandt; HHV-3, plasmid pCAGGS
ORF47.12 [50], a gift from Charles Grose; HHV-4, plasmid
pcDNA3.1-FLAG BGLF4 [112], a gift from Thomas Stamminger;
HHV-5, ppUL97-V5 [53], a gift from Mark Prichard; HHV-6
and HHV-7, cosmids pMF147-19 [113] and I6 (unpublished)
respectively, gifts from Steven Dewhurst; HHV-8, plasmid pND
ORF36 [55], a gift from Paul Luciw. Plasmid pSG5-UL13 39 HA
[48] kindly provided by Lynda Morrison, was used to express a
kinase-active C-terminally tagged HHV-2 CHPK from the SV40
promoter.
Sequence alignment and phylogenic tree assembly
The sequence comparison was created with a ClustalW
alignment in MEGA 4 [114], and utilized only the kinase domains
of the indicated proteins. The parameters were as follows: Pairwise
alignment - gap opening penalty 2, gap extension penalty 0.05;
multiple alignment - gap opening penalty 5, gap extension penalty
1, utilizing the Blosum matrix. The alignment was heuristically
adjusted to align kinase domain III. The phylogenic tree was
constructed by the neighbor-joining method, in MEGA 4 [114].
Western blots, indirect immunofluorescence, and
antibodies
Equal amounts of protein (determined by Bradford assay) from
cell lysates prepared in radioimmunoprecipitation assay (RIPA)
buffer with protease inhibitors were analyzed by Western blotting
(WB) as previously described [115]. Cells grown on glass coverslips
were processed for indirect immunofluorescence (IF) as previously
described [116]. Images were produced with a Nikon Eclipse
TE2000-S or Zeiss Axiovert 200M microscope. The following
antibodies were from commercial sources: HA (IF: Roche 3F10;
WB: Covance MMS-101P), PML (Santa Cruz sc-966), Total Rb
(Cell Signaling 9309), Rb p-Ser807/811 (Cell Signaling 9308), Rb
p-Ser780 (Cell Signaling 9307), Rb p-Thr821 (Biosource 44-
582G), Lamin A/C (Novocastra NCL-Lam-A/C) Lamin A p-
Ser22 (Cell Signaling 2026), Flag (Sigma F1804), V5 (Invitrogen
R960-25) Tubulin (DM 1A Sigma), PGK (Invitrogen 459250).
The HCMV IE1 antibody 1B12 has been previously described
[117].
Assays
Rb Phosphorylation in Saos-2 cells and Cdk activity in S.
cerevisiae cdc28-13 cells were determined as previously described
[46]. For the nuclear lamina disruption assays, U-2 OS cells grown
on coverslips were co-transfected with expression plasmids for the
indicated CHPK and pEGFPhLA-WT [72] that expresses a GFP-
lamin A fusion protein (a kind gift of David Gilbert). Coverslips
were harvested 24h later, stained for the CHPK, and then
visualized by fluorescence microcopy. At least 300 CHPK- and
GFP-lamin A-positive cells for each co-transfection were analyzed
in three independent experiments. For the lamin A/C serine-22
phosphorylation assay, U-2 OS cells grown on coverslips were
transfected with expression plasmids for the indicated CHPK.
Cells were then incubated in media containing 0.1% FBS for
36 hours before harvesting the coverslips, staining for the CHPK
and lamin A phosphorylated at serine-22, and visualization by
fluorescence microscopy. At least 200 (wild type) or 100 (kinase-
deficient) CHPK-positive cells were analyzed in three separate
experiments. For PML-NB disruption assays, U-2 OS cells grown
on coverslips were transfected with an expression plasmid for the
indicated CHPK or pCGN-IE1 [117]. Coverslips were harvested
24h later, stained for PML and the CHPK, and then visualized by
fluorescence microscopy. The number of PML-NBs in 100
individual CHPK- or IE1-positive cells was counted in each of
three independent experiments. For the aggresome disruption
assays, U-2 OS cells grown on coverslips were co-transfected with
expression plasmids for the indicated CHPK and either p3PK-
Flag-Ataxin-1 or p3PK-Flag-Ataxin-1 K722T [90] that express,
respectively, nuclear or cytoplasmic versions of the ataxin-1 Q82
protein that spontaneously forms large aggregates fused to GFP
(kindly provided by Harry Orr). Coverslips were harvested 24h
later, stained for the CHPK, and visualized by fluorescence
microscopy. At least 200 (nuclear) or 300 (cytoplasmic) CHPK-
and ataxin-positive nuclei were analyzed in three (nuclear) or four
(cytoplasmic) separate experiments.
Supporting Information
Figure S1 Western blot analysis of lysates from the lamina
disruption experiment presented in Figure 3A. Lysates from the
transfected U-2 OS cells shown in Figure 3A were analyzed by
Western blot with the indicated antibodies. Note that these cells
express both endogenous lamin A as well as the ectopic lamin A-
GFP fusion protein, and both are recognized by the lamin A
antibody. The HA antibody recognizes the CHPKs, and tubulin
serves as a loading control. Numbers represent the different
human herpesvirus CHPKs. EV, empty vector.
Found at: doi:10.1371/journal.ppat.1001092.s001 (0.23 MB TIF)
Figure S2 Western blot analysis of lysates from the lamin A
phosphorylation experiment presented in Figures 3C, 3D, and 3E.
Lysates from the transfected U-2 OS cells shown in Figure 3C, 3D,
and 3E were analyzed by Western blot with the indicated
antibodies. The HA antibody recognizes both wild type and kinase
deficient (KD) CHPKs, and tubulin serves as a loading control.
Numbers represent the different human herpesvirus CHPKs. EV,
empty vector.
Found at: doi:10.1371/journal.ppat.1001092.s002 (0.36 MB TIF)
Figure S3 Western blot analysis of lysates from the S. cerevisiae
Cdk complementation asay shown in Figure 4. Lysates from S.
cerevisiae harboring plasmids expressing the indicated kinase and
treated with galactose were analyzed by Western blot with the
indicated antibodies. The HA antibody recognizes all CHPKs
except for the HHV-5 protein, which is visualized with the V5
antibody. Cdk1 expression was not analyzed. PGK (3-Phospho-
glycerokinase) serves as a loading control. Numbers represent the
different human herpesvirus CHPKs. EV, empty vector.
Found at: doi:10.1371/journal.ppat.1001092.s003 (0.22 MB TIF)
Figure S4 Western blot analysis of lysates from the PML-NB
disruption experiment presented in Figure 5. Lysates from
transfected U-2 OS cells shown in Figure 5A were analyzed by
Western blot with the indicated antibodies. The HA antibody
recognizes the CHPK, and tubulin serves as a loading control. The
approximate localization of molecular weight markers (in Kilo
Daltons, kDa) is displayed. Numbers represent the different
human herpesvirus CHPKs.
Found at: doi:10.1371/journal.ppat.1001092.s004 (0.20 MB
TIF)
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disruption experiments presented in Figure 6. (A) Lysates from
transfected U-2 OS cells shown in Figure 6A were analyzed by
Western blot with the indicated antibodies. The nuclear ataxin Q82
protein (Flag-Atx-Nuc) is detected with the Flag antibody. The HA
antibody recognizes the CHPKs, and tubulin serves as a loading
control. Numbers represent the different human herpesvirus CHPKs.
EV, empty vector. (B) Lysates from transfected U-2 OS cells shown in
Figure 6C were analyzed by Western blot with the indicated
antibodies. The cytoplasmic ataxin Q82 K722T protein (Flag-Atx-
Cyto) is detected with the Flag antibody. The HA antibody recognizes
the CHPKs, and tubulin serves as a loading control. Numbers
represent the different human herpesvirus CHPKs. EV, empty vector.
Found at: doi:10.1371/journal.ppat.1001092.s005 (0.41 MB TIF)
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